Answer
Cipaglucosidase alfa is contraindicated in life-threatening hypersensitivity to the active substance or any excipient when rechallenge was unsuccessful, and in patients with a contraindication to miglustat.
Sources for this answer
- Pombiliti 105 mg powder for concentrate for solution for infusionAmicus Therapeutics UK Ltd · emc · SmPC §4.3 Contraindications · Version 3Document updated
Sources checked